InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 254.60
+1.00 (0.39%)
May 20, 2026, 1:30 PM IDT
InterCure Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 270.2 | 238.85 | 355.55 | 388.68 | 219.68 | |
Revenue Growth (YoY) | 13.13% | -32.82% | -8.52% | 76.93% | 237.78% |
Cost of Revenue | 229.5 | 196.79 | 246.95 | 216.67 | 117.11 |
Gross Profit | 40.7 | 42.05 | 108.6 | 172.01 | 102.56 |
Selling, General & Admin | 93.4 | 107.89 | 95.88 | 92.62 | 50.42 |
Research & Development | 0.39 | 0.41 | 0.39 | 0.63 | 1.24 |
Other Operating Expenses | -30 | 19.35 | 9.64 | 29.63 | 14.4 |
Operating Expenses | 66.21 | 129.94 | 108.5 | 131.78 | 72.51 |
Operating Income | -25.51 | -87.89 | 0.11 | 40.23 | 30.05 |
Interest Expense | -19.99 | -20.65 | -24.22 | -14.69 | -0.42 |
Interest & Investment Income | - | 2.7 | 5.38 | 0.84 | 0.13 |
Earnings From Equity Investments | 0.3 | - | - | - | - |
Currency Exchange Gain (Loss) | - | -0.02 | -0.05 | 7.33 | -4.54 |
Other Non Operating Income (Expenses) | 3.13 | -2.15 | -0.83 | -0.27 | -4.63 |
EBT Excluding Unusual Items | -42.08 | -108 | -19.61 | 33.44 | 20.6 |
Impairment of Goodwill | - | - | -63.1 | - | - |
Gain (Loss) on Sale of Investments | -2.03 | -12.22 | -3 | -0.17 | -1.87 |
Asset Writedown | - | - | -4.59 | - | - |
Other Unusual Items | - | 32.9 | 29.01 | 10.57 | - |
Pretax Income | -44.1 | -87.32 | -61.29 | 43.84 | 18.73 |
Income Tax Expense | -7.32 | -14.53 | 2.25 | 0.09 | 11.44 |
Earnings From Continuing Operations | -36.78 | -72.79 | -63.53 | 43.75 | 7.29 |
Minority Interest in Earnings | 1.07 | 5 | 1.57 | 1.07 | -2.6 |
Net Income | -35.71 | -67.8 | -61.96 | 44.82 | 4.69 |
Net Income to Common | -35.71 | -67.8 | -61.96 | 44.82 | 4.69 |
Net Income Growth | - | - | - | 855.63% | - |
Shares Outstanding (Basic) | 54 | 46 | 46 | 45 | 38 |
Shares Outstanding (Diluted) | 54 | 46 | 46 | 45 | 41 |
Shares Change (YoY) | 17.96% | 0.65% | 0.48% | 11.05% | 60.81% |
EPS (Basic) | -0.66 | -1.48 | -1.36 | 0.99 | 0.12 |
EPS (Diluted) | -0.66 | -1.48 | -1.36 | 0.99 | 0.11 |
EPS Growth | - | - | - | 798.39% | - |
Free Cash Flow | 13.29 | -71.3 | -56.25 | 31.53 | 16.11 |
Free Cash Flow Per Share | 0.25 | -1.55 | -1.23 | 0.69 | 0.39 |
Gross Margin | 15.06% | 17.61% | 30.54% | 44.26% | 46.69% |
Operating Margin | -9.44% | -36.80% | 0.03% | 10.35% | 13.68% |
Profit Margin | -13.22% | -28.38% | -17.43% | 11.53% | 2.14% |
Free Cash Flow Margin | 4.92% | -29.85% | -15.82% | 8.11% | 7.33% |
EBITDA | -8.36 | -78.22 | 8.29 | 51.93 | 37.45 |
EBITDA Margin | -3.09% | -32.75% | 2.33% | 13.36% | 17.05% |
D&A For EBITDA | 17.15 | 9.67 | 8.18 | 11.7 | 7.39 |
EBIT | -25.51 | -87.89 | 0.11 | 40.23 | 30.05 |
EBIT Margin | -9.44% | -36.80% | 0.03% | 10.35% | 13.68% |
Effective Tax Rate | - | - | - | 0.21% | 61.07% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.